Kriya Therapeutics
Claire Pasquinelli is an experienced professional in the field of CMC program management, currently serving as VP, CMC Program Management at Kriya Therapeutics, Inc. since March 2022. With a robust background that includes roles as Sr. Director and Director within the same company, Claire has provided strategic leadership for the development and tech transfer of gene therapy products. Prior experience includes Director of CMC Project Management at Sio Gene Therapies and various positions at Biogen, where Claire managed technology transfers and initiated significant process improvements. Educational credentials include an M.S. in Chemical Engineering and a B.S. in Biological Engineering from North Carolina State University.
This person is not in any teams
This person is not in any offices
Kriya Therapeutics
2 followers
Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs.